NCT04847687View on ClinicalTrials.gov

Investigation of Hospitalisation Times and Mortality According to Drug Dose in Patients Given Systemic Methylprednisolone With a Pre-diagnosis of Covid-19 Pneumonia; Retrospective Study

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions

COVID-19MethylprednisolonePneumonia

Interventions

DRUG

methylprednisolone

Patients who are hospitalized with a pre-diagnosis of severe COVID-19 pneumonia and who are started on methylprednisolone will be divided into two groups according to the drug dose. Groups will be compared in terms of length of hospital stay, intensive care needs and prognosis.

Trial Locations (1)

16115

Bursa Yüksek İhtisas EAH, Bursa

All Listed Sponsors

lead

Bursa Yuksek Ihtisas Training and Research Hospital

OTHER_GOV

NCT04847687 - Investigation of Hospitalisation Times and Mortality According to Drug Dose in Patients Given Systemic Methylprednisolone With a Pre-diagnosis of Covid-19 Pneumonia; Retrospective Study | Biotech Hunter | Biotech Hunter